Trial Profile
Adalimumab regulates intracellular TNFalpha production in patients with rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 11 Dec 2015 New trial record